Navigation Links
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
Date:8/24/2014

France
+33 (0) 1 70 77 09 44
UK
+44 (0) 203 367 9453
U.S.
+1 866 907 5928

Alirocumab is currently under clinical development and its safety and efficacy have not been fully evaluated by any regulatory authority.

About Sanofi
Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs.  Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.  Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York, that discovers, invents, develops, manufactures, and commercializes biologic medicines for the treatment of serious medical conditions.  Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended.  Forward-looking statements are statements that are not historical facts.  These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, ope
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Regeneron Announces Upcoming 2014 Investor Conference Presentations
2. Regeneron Reports Second Quarter 2014 Financial and Operating Results
3. Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
4. Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration
5. Regeneron Announces Upcoming 2013 Investor Conference Presentation
6. Sanofi and Regenerons Dupilumab Named "Clinical Advance of the Year" by Scrip Intelligence
7. Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
8. Regeneron Reports Third Quarter 2013 Financial and Operating Results
9. Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
10. Regenerons Eylea Now Captures One-Quarter Of Wet AMD Patient Share, Surpassing Share Of Roche/Genentechs Lucentis
11. Quarterly Financial Results and Development Program Updates - Research Report on Regeneron, DaVita, Celldex, Isis, and VIVUS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... NEW PROVIDENCE, N.J. , Sept. 16, 2014 /PRNewswire/ ... paper on the critical elements of installing and maintaining ... systems at the American Society of Plumbing Engineers Convention ... Chicago Sheraton Hotel and Towers in Chicago ... , program manager of Hospital Services for Linde Healthcare, ...
(Date:9/15/2014)... NEW YORK , Sept. 16, 2014 ... the Hereditary Neuropathy Foundation (HNF) announced today an agreement ... Charcot-Marie-Tooth (CMT) disease and support the development of a ... Pharnext will provide financial support to several HNF,s initiatives ... a specific section in the HNF website featuring  HNF ...
(Date:9/15/2014)... 15, 2014 /CNW/ - Health Minister Rona Ambrose ... available for donation over $2.5 million in personal protective equipment ... the global response to the Ebola outbreak in ... a shortage of equipment in the affected countries and has ... workers in the affected countries. Personal protective ...
Breaking Medicine Technology:Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 2Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced ... offer and sell shares of its common stock and warrants ...  The Company also intends to grant the underwriters a 45-day ... shares and warrants sold in the public offering to cover ...
... Food and Drug Administration has licensed HEMACORD™ (Hematopoietic ... cell transplantation, the first such approval of a ... According to the Food and Drug Administration,s ... is "indicated for use in unrelated donor hematopoietic ...
Cached Medicine Technology:ADVENTRX Announces Public Offering of Stock 2ADVENTRX Announces Public Offering of Stock 3FDA Approves New York Blood Center's HEMACORD™ for Stem Cell Transplantation 2FDA Approves New York Blood Center's HEMACORD™ for Stem Cell Transplantation 3
(Date:9/16/2014)... 16, 2014 On September 14, the ... at the 2014 Buffalo Bills Alumni Foundation VIP Tailgate ... , Bills legend and NFL Hall-of-Famer Joe DeLamielleure, who ... in honoring Strassle for her dedication in overcoming hearing ... inspire others in her community to do the same. ...
(Date:9/16/2014)... *Anyone who is interested in learning more about ... visit Avail Clinical Research on the web ( http://www.availclinical.com/trial/common-cold/ ... Why Are Volunteers Needed? , The common cold is ... While infections may not be as deadly as in ... visits to the doctor than any other medical condition ...
(Date:9/16/2014)... Washington, DC (PRWEB) September 16, 2014 ... a chief concern for health plans, employers and PBMs ... the top of their drug lists. Once a concentrated, ... The Sept. 25 webinar from Atlantic Information Services, Inc. ... Plan/Employer Strategies,” will offer details of what one ...
(Date:9/16/2014)... Richmond, VA (PRWEB) September 16, 2014 ... Museum of Virginia this fall. Reflecting on what it ... Ethics: Expanding Community Vision investigates unique and thought-provoking topics. ... people to be inspired to look at their world ... provoking and set the stage for truly enlightening dialogue,” ...
(Date:9/16/2014)... September 16, 2014 Botanica ... specials this month, kicking off September with fall-themed ... in Clearwater, FL chose to highlight lumablanc® which ... activation upon contact with the skin. , Lumablanc® ... their best-selling lumafirm® anti-aging line. The brightening formula, ...
Breaking Medicine News(10 mins):Health News:The HearStrong Foundation and the Buffalo Bills Alumni Foundation Celebrated HearStrong Champion During 2014 Alumni Weekend 2Health News:Avail Clinical Research Is Looking for Healthy Adults Who Are Interested in Participating in a Common Cold Clinical Trial near Orlando, Florida 2Health News:Avail Clinical Research Is Looking for Healthy Adults Who Are Interested in Participating in a Common Cold Clinical Trial near Orlando, Florida 3Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3
... in Florida, patients with glaucoma have a new treatment option ... is available at Mayo Clinic and takes about 20 minutes, ... the vision. , "The goal of this procedure is ... Shetty, M.D. He says that some patients have been ...
... The StrionAir System A130,air purification product is ... "It provides HVAC efficiency to the third power," ... First, it achieves LEED-qualifying MERV* 13 efficiency ... That,s half the pressure drop of the,newest "green" ...
... importance of skin cancer self-examination, LOS ANGELES, ... a public service initiative that partners with organizations,and ... for,skin health, has tapped actress Malin Akerman to ... skin cancer detection. As the #1,dermatologist recommended skincare ...
... FAIRFAX, Va., June 25 Country music,superstar and "The ... Honorary Chair of the 2008 Walk for Food Allergy: ... in 26 cities across the country as well as,online, ... (FAAN) to,increase awareness and raise money for education and ...
... Pathway Medical Technologies,Inc., an innovator of endovascular treatments ... granted another patent for its,Pathway PV(TM) Atherectomy System. ... property related to Pathway Medical,s innovative,atherectomy system, which ... in the legs. Pathway Medical has a total ...
... on July 1, Workout and Recovery Drinks Developed by UT,s Dr. John Ivy ... Team Swim ... Coach, AUSTIN, Texas, June ... on Sunday in Omaha at,the U.S. Olympic Team Trials for Swimming to cheer ...
Cached Medicine News:Health News:Glaucoma procedure now available at Mayo Clinic aims to prevent further eye damage 2Health News:StrionAir System A130 Air Purification Product Reduces Fan Energy by More Than 10 Percent 2Health News:Neutrogena(R) Partnership For Skin Health Taps Malin Akerman to Educate About Skin Cancer Detection 2Health News:Neutrogena(R) Partnership For Skin Health Taps Malin Akerman to Educate About Skin Cancer Detection 3Health News:Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 2Health News:Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 3Health News:Austin Company Makes a Splash at U.S. Olympic Team Swimming Trials 2Health News:Austin Company Makes a Splash at U.S. Olympic Team Swimming Trials 3Health News:Austin Company Makes a Splash at U.S. Olympic Team Swimming Trials 4Health News:Austin Company Makes a Splash at U.S. Olympic Team Swimming Trials 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: